Tiffany Eddins
Family · Lecanto, FLNPI 1063247575
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,853 of the $3,309 with a category attached, or 86.2%. It is spread thinly across 38 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations.
Across 116 payments — averaging $28.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$468
- Novartis$234
- Astellas Pharma US Inc$231
- Merck$217
- Seagen Inc.$192
- Puma Biotechnology, Inc.$186
- plus $2K from 32 others
What the payments were for
- Food & beverage$2,85386%
- Education$45614%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 12 | $468 |
| Novartis | 10 | $234 |
| Astellas Pharma US Inc | 5 | $231 |
| Merck | 9 | $217 |
| Seagen Inc. | 2 | $192 |
| Puma Biotechnology, Inc. | 5 | $186 |
| Daiichi Sankyo Inc. | 7 | $170 |
| Bayer | 7 | $166 |
| Sanofi US Services Inc. | 1 | $104 |
| Johnson & Johnson | 4 | $104 |
| AstraZeneca | 4 | $98 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
| GSK | 3 | $84 |
| Beone Medicines USA, Inc. | 3 | $83 |
| Springworks Therapeutics, Inc. | 1 | $61 |
| Sanofi | 3 | $59 |
| Kyowa Kirin, Inc. | 2 | $59 |
| E.r. Squibb & Sons, L.L.C. | 2 | $49 |
| Eisai Inc. | 3 | $49 |
| AbbVie | 2 | $47 |
| Genentech USA, Inc. | 2 | $44 |
| Stemline Therapeutics Inc. | 2 | $41 |
| Pharmacosmos Therapeutics Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Boehringer Ingelheim | 2 | $37 |
| Geron Corporation | 2 | $35 |
| Array Biopharma Inc | 2 | $34 |
| Gilead | 1 | $34 |
| Sobi, Inc | 1 | $33 |
| Pfizer | 4 | $33 |
| Genmab U.S., Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $32 |
| ADC Therapeutics America, Inc. | 1 | $28 |
| Pharmaessentia USA Corporation | 1 | $25 |
| AVEO Pharmaceuticals, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| EMD Serono, Inc. | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,309 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Other family in Lecanto
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.